Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boumsell

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Immunology|October 1, 1986
Control of cell proliferation within the human thymus. A very limited thymocyte subpopulation generates a suppressive activityC Gelin, L Boumsell, A Bernard
Presse Medicale (Paris, France : 1983)|December 10, 1999
[Contribution of immunotherapy to the treatment of T-cell lymphoma of the skin]M Bagot, L Boumsell, A Bensussan
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|September 20, 1982
[Identification of lymphocyte populations producing alpha-interferon by monoclonal antibodies]P Lebon, A Bernard, L Boumsell
Archivum Immunologiae Et Therapiae Experimentalis|May 12, 2001
The receptors regulating natural cytotoxic effector functionsM Nikolova, L Boumsell, A Bensussan
Blood|February 15, 1990
Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemiaC Gouttefangeas, A Bensussan, L Boumsell
Cellular Immunology|March 15, 1976
Complement inhibitor(s) released from leukocytes. II. Evidence that lymphocytes release and produce an inhibitor of C2 activationA Bernard, L Boumsell, R A Good
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Three different erythrocyte surface molecules are required for spontaneous T cell rosette formationA Bernard, H C Tran, L Boumsell
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopesP Brottier, L Boumsell, C Gelin, et al.
The American Journal of Pathology|March 1, 1991
Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastasesK Koretz, P Schlag, L Boumsell, et al.
The Journal of Pathology|October 1, 1993
Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010L Krenács, L Tiszalvicz, T Krenács, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Immunology|October 1, 1986
Control of cell proliferation within the human thymus. A very limited thymocyte subpopulation generates a suppressive activityC Gelin, L Boumsell, A Bernard
Presse Medicale (Paris, France : 1983)|December 10, 1999
[Contribution of immunotherapy to the treatment of T-cell lymphoma of the skin]M Bagot, L Boumsell, A Bensussan
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|September 20, 1982
[Identification of lymphocyte populations producing alpha-interferon by monoclonal antibodies]P Lebon, A Bernard, L Boumsell
Archivum Immunologiae Et Therapiae Experimentalis|May 12, 2001
The receptors regulating natural cytotoxic effector functionsM Nikolova, L Boumsell, A Bensussan
Blood|February 15, 1990
Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemiaC Gouttefangeas, A Bensussan, L Boumsell
Cellular Immunology|March 15, 1976
Complement inhibitor(s) released from leukocytes. II. Evidence that lymphocytes release and produce an inhibitor of C2 activationA Bernard, L Boumsell, R A Good
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Three different erythrocyte surface molecules are required for spontaneous T cell rosette formationA Bernard, H C Tran, L Boumsell
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopesP Brottier, L Boumsell, C Gelin, et al.
The American Journal of Pathology|March 1, 1991
Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastasesK Koretz, P Schlag, L Boumsell, et al.
The Journal of Pathology|October 1, 1993
Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010L Krenács, L Tiszalvicz, T Krenács, et al.
Pageof 15